FLUDARABİN-KARMUSTİN-MELFALAN(FCM) PROTOKOLÜ(AZALTILMIŞ YOĞUNLUKLU)(RIC)

Kaynaklar:

1- Marks R, Potthoff K, Hahn J et al. 2008 "Reduced-toxicity conditioning with fludarabine, BCNU, and melphalan in allogeneic hematopoietic cell transplantation: particular activity against advanced hematologic malignancies". Blood. 2008 Jul 15;112(2):415-25.

2- Wäsch R, Reisser S, Hahn J et al. 2000 "Rapid achievement of complete donor chimerism and low regimen-related toxicity after reduced conditioning with fludarabine, carmustine, melphalan and allogeneic transplantation" . Bone Marrow Transplant. Aug;26(3):243-50.

3- Bertz H, Potthoff K, Finke J et al. 2003 " Allogeneic stem-cell transplantation from related and unrelated donors in older patients with myeloid leukemia".J Clin Oncol. Apr 15;21(8):1480-4.

4- Finke J, Egger M, Grullich C et al. 2003 "Myeloablative reduced conditioning with fludarabine, BCNU, melphalan (FBN) and stem cell transplantation from unrelated donors in elderly patients with active AML/MDS". Blood ;102:246a.

5- Spyridonidis A, Bertz H, Ihorst G et al. 2005 " Hematopoietic cell transplantation from unrelated donors as an effective therapy for older patients (> or = 60 years) with active myeloid malignancies".Blood. May 15;105(10):4147-8.